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Objective: We investigated the reliability of susceptibility weighted imaging (SWI) in detecting cerebral
microbleeds in stroke patients which predicts future recurrence and judges thrombolytic drugs.
Methods: A total of 124 patients referred from stroke unit underwent conventional MRI and SWI. Two
observers reviewed twice the SWI separately to identify presence, anatomical location and count of cere-
bral microbleeds. Inter and intraobserver agreement were calculated using Kappa statistics.
Results: In SWI, intraobserver agreement for presence of CMBs in any brain location was almost perfect
for both observers (K = 0.86, p < 0.01, 95% CI = 0.83–0.89) (K = 0.94, p < 0.01, 95% CI = 0.92–0.96), the
interobserver agreement was almost perfect for first and second times (k = 0.95, p < 0.01, 95%
CI = 0.94–0.96), (k = 0.84, p < 0.01, 95% CI = 0.8–0.89). Intraobserver agreement was almost perfect for
the identified CMBs in each of the three main brain locations : lobar (k = 0.9, p < 0.01 95% CI = 0.8–1), deep
(k = 0.81 p < 0.01, 95% CI = 0.71–0.91) and infratentorial (k = 0.95 p < 0.01, 95% CI = 0.9–1).
Conclusion: SWI is an important reliable technique allows accurate detection of CMBs occurring in asso-
ciation with hemorrhage in acute and chronic stroke and should be included in the protocols for assess-
ment of stroke to help in choice of proper treatment and prediction of future attacks.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Cerebral microbleeds (CMBs) are identified as rounded, small,
hypointense foci seen on T2⁄-MRI sequences. Pathologically, CMBs
are composed of hemosiderin, occurring from leakage through
small cerebral vessels and surrounded by macrophages within
brain parenchyma [1,2].
CMBs have great clinical implications [3,4] being linked to
hypertension [5,6], small blood vessel diseases, stroke whether
ischemic or hemorrhagic [7], cognitive impairment, traumatic
brain injury and mortality in different populations [8,9].
In Hemorrhagic stroke patients and intracerbral Hematoma
(ICH), CMBs are associated with higher risk of ICH and ischemic
stroke recurrence, independent of potential confounding factors;
the co-existence of CMBs and ischemic stroke specially in patients
receiving antiplatelet agents is associated with an increased risk of
future stroke [9,10].Susceptibility weighted imaging (SWI) was originally called
‘High-Resolution Blood oxygen level dependent (BOLD) Venogra-
phy’ which gives an expanded visibility of the venous vasculature
in the brain. Susceptibility weighted imaging based magnetic res-
onance venography uses the fact that paramagnetic deoxyhe-
moglobin in veins causes a shift in resonance frequency between
the venous vessel and the surrounding tissue [11].
The sequence of SWI is a fully flow-compensated, high-spatial-
resolution conventional T2⁄-weighted sequence [12,13] which can
detect hemorrhage as early as six hours and can reliably detect
acute intracerebral parenchymal, as well as subarachnoid hemor-
rhage [12]. Moreover, the use of filtered phase information leads
to increase the contrast in magnitude images. It provides data
about the difference in susceptibility between tissues; hence used
to visualize smaller veins and other sources of susceptibility effects
e.g. hemosiderin, ferritin and calcium [14]. Currently, SWI is
considered the most sensitive modality for detection of
CMBs as it can detect more microbleeds than GRE imaging.
Therefore, SWI is more sensitive than GRE sequence in CMBs detec-
tion [9,14,15].
The aim of this study was to investigate the reliability of SWI in
detection of CMBs in stroke patients.stroke
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2. Patient and methods
2.1. Patients
This is a prospective study that included 124 consecutive
patients with haemorrhagic brain lesions referred from stroke unit.
All patients were examined by a 1.5-T MRI machine. Fourteen
patients were excluded because of poor quality of scans. The total
number of patients with both conventional MRI and SWI
sequences of appropriate diagnostic quality was 110 (mean age,
54 years; 59% male).
2.2. MRI protocol
All patients underwent MR imaging using 1.5 T MR Unit (Philips
Ingenia, Philips Medical Systems, the Netherlands) with head coil
in the supine position with the head first by the following param-
eters: (Cranial, axial and sagittal FSE T1WI (TR: 580 ms, TE: 15 ms,
Flip angle: 70), T2WI (TR: 4000 ms, TE: 100 ms, Flip angle: 90) and
FLAIR (TR: 11,000 ms, TE: 110 ms, TI: 2800 ms, Flip angle: 90),
DWI: (TR: 3614 ms, TE: 160 ms, TI: 2800 ms, axial, Flip angle:
90). SWI then obtained with sequence(Ven-BOLD) [16] venography
using the following parameters: (TR: 25 ms, TE: 35 ms, axial plane,
Flip angle: 20, Matrix: 256  256, FOV: 256 mm, Total time
11 min). SWI post-processing techniques was done using minIP
reconstruction integrated in the MR imaging system.
2.3. Image analysis
Two radiologists with 25 and 15 years experience in neuroradi-
ology reviewed SWI images separately two times with 8 weeks
interval time. The observers were blinded to each other’s results
and to clinical data of the patients.
The images were analyzed according to the presence, localiza-
tion age and size of the detected Heamorrhagic brain lesion and
presence of microbleeds.
Categorization of the heamorrhagic brain lesion into primary
(hypertensive hematoma) or secondary (Hemorrhagic infarcts,
vascular malformations, tumors, and cerebral venous sinus
thrombosis).
CMBs were diagnosed as low signal intensity homogeneous
round lesions up to 10 mm in size on SWI images [4]. We excluded
CMBs mimickers e.g. linear vascular flow voids representing blood
vessels, mineral deposits in basal ganglia, bony or sinus artifacts,
parts of large heamatomas, iron or calcium deposits in the globus
pallidus [17] and calcifications within choroid plexus and pineal
gland. The location of CMBs was lobar (cortical, subcortical
regions), deep (basal ganglia, thalamus, internal capsule, external
capsule and deep periventricular white matter) and infratentorial
(cerebellum and brain stem) based on Microbleed Anatomical
Rating Scale (MARS) [2].
2.4. Statistical analysis
For statistical analysis, SPSS 21.0 for Windows (SPSS, Chicago,
IL) was used. The degree of agreement was defined according to
the method of Landis and Koch with weighted Cohen’s kappa’s,
as follows: for slight agreement, the kappa value ranged from
0.00 to 0.20;for fair agreement, the kappa value ranged from 0.21Please cite this article in press as: El-Serougy LG et al. Reliability of magnetic sus
patients. Egypt J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.20to 0.40; for moderate agreement, the kappa value ranged from
0.41 to 0.60; for substantial agreement, the kappa value ranged
from 0.61 to 0.80;and for almost perfect greement, the kappa value
ranged from 0.81 to 0.99. A (P) value less than 0.01indicated a sta-
tistically significant difference.
3. Results
3.1. Demographic and clinical data
The study included 110 patients (46 females and 64 males),
their ages ranged from 18 to 90 years with mean age of 54y at time
of presentation. There was no difference in clinical presentations
between patients with and without CMBs. There was no statistical
significant association between sex and presence of CMBs.
3.2. The radiologic findings
In the study group, there were 78 hypertensive hematoma, 10
hemorrhagic transformation of ischemic infarction, 6 primary
brain tumors and 10 metastatic tumors, vascular malformations
in 2 cases and 4 cases with cerebral venous sinus thrombosis.
3.3. CMBs detection
CMBs were detected in 26 (23.6%) & 28 (25.4%) patients by
observer 1 & 2 for first time, 22 (20%) & 26 (23.6%) patients by
observer 1 & 2 in second time. CMBs were associated with hyper-
tensive hematoma in 19 cases (73%) and hemorrhagic transforma-
tion of ischemic infarction in 7 cases (27%). None of these
microbleeds were detected on CT examination or conventional
MRI images. Eighty-four (76.3%) & 82 (74.5%) cases were negative
for CMBs by observer 1 & 2 in first time, 88 (80%) & 84 (76.3%) were
negative for CMBs by observer 1 & 2 in second time.
3.4. Reliability of SWI in detection of CMBs
Intraobserver agreement for CMBs presence in any brain loca-
tion was almost perfect for both observers (K = 0.86, p < 0.01, 95%
CI = 0.83–0.89) (K = 0.94, p < 0.01, 95% CI = 0.92–0.96), the interob-
server agreement was almost perfect for first and second times
(k = 0.95, p < 0.01, 95% CI = 0.94–0.96), (k = 0.84, p < 0.01, 95%
CI = 0.8–0.89) as shown in Table 1.
A total number of 256 CMBs were detected by observer1 and
260 CMBs by observer 2. The most prevalent location was deep
location (n = 110, 111, 43%) followed by infratentorial location
(n = 93, 92, 36%) and lastly the lobar location (n = 54, 56, 21.5%)
(Table 2).
Intraobserver agreement was almost perfect for identified CMBs
in each of the three main brain locations: lobar (k = 0.9 p < 0.01,
95% CI = 0.8–1), deep (k = 0.81 p < 0.01, 95% CI = 0.71–0.91) and
infratentorial (k = 0.95 p < 0.01, 95% CI = 0.9–1) (Table 2).
We could not calculate the interobserver agreement for identi-
fied CMBs in each of the three main brain location because of the
small number of patients with microbleeds in each location.
4. Discussion
SWI is currently considered a technique of choice for CMBs
detection with higher sensitivity than other imaging modalities
including CT, conventional MRI [4,8,9,16] & GRE [15,18]. This was
confirmed in our study because non of the CMBs detected on
SWI were found on CT or conventional MRI (Figs. 1 and 2). SWI
has highlighted the association between CMBs and stroke [19].
Detection of CMBs in stroke patients is extremely importantceptibility weighted imaging in detection of cerebral microbleeds in stroke
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Table 1
Reliability of SWI in detection of CMBs at any brain location in the study group.
Microbleeds At any location Presence of CMBs
n (%), observer 1 n (%), observer 2 IO (95% CI) IEO(95%CI)
First time 26 (23.6) 28 (25.4) 0.86** (0.83–0.89) 0.95** (0.94–0.96)
Second time 22 (20) 26 (23.6) 0.94** (0.92–0.96) 0.84** (0.8–0.89)
Kappa Agreement
<0 Less than chance agreement.
0.01–0.20 Slight agreement.
0.21–0.40 Fair agreement.
0.41–0.60 Moderate agreement.
0.61–0.80 Substantial agreement.
0.81–0.99 Almost perfect agreement.
** Significant at 0.01 level, IO = intraobserver, IEO = interobserver, CI = confidence interval.
Table 2
Intraobserver variability of SWI in identified CMBs in each of the three main
anatomical brain locations.
Location Identified CMBs
n (%), observer1 n (%), observer 2 IO (95% CI)
Lobar 54 (21.1) 56 (21.5) 0.9** (0.8–1)
Deep 110 (43) 111 (42.7) 0.81** (0.71–0.91)
Infratentorial 92 (35.9) 93 (35.8) 0.95** (0.9–1)
Total 256 260 –
Kappa Agreement
<0 Less than chance agreement.
0.01–0.20 Slight agreement.
0.21–0.40 Fair agreement.
0.41–0.60 Moderate agreement.
0.61–0.80 Substantial agreement.
0.81–0.99 Almost perfect agreement.
** Significant at 0.01 level, IO = intraobserver, CI = confidence interval.
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using intra-arterial thrombolytics and after using antithrombotic
medicines for acute stroke [8,15,16,19,20].we confirmed the relia-
bility of SWI in detection of CMBs in stroke patients by testing the
interobserver and intraobserver agreement in 110 stroke patients.Fig. 1. Female patient 71 years old presented to the emergency hospital with loss of cons
ill defined iso intense area with blood signal inside in the left parieto-occipital region.
detected in the left & right parietal regions (arrows).
Please cite this article in press as: El-Serougy LG et al. Reliability of magnetic sus
patients. Egypt J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.20The results of this study yielded almost perfect inter and
intraobserver agreement in detection of CMBs in any brain location
using SWI, as well as in specific location which are comparable
with the results of Gregorie et al., 2011. However, the authors were
testing the reliability of MARS system in localization of CMBs uti-
lizing SWI technique [2].
CMBs were found in about (20–25.4%) of cases presented with
acute stroke, 19 cases of them with ICH (73%) while found in 7
cases with ischemic stroke (27%) parallel to the results of Lovelock
et al. & Imazumi et al. [5,17].Also multiple studies showed that
CMBs was detected in 33–80% of patients with primary intracere-
bral hemorrhages, in 21–26% of patients with ischemic stroke, and
in 5–6% of asymp-tomatic or healthy elderly individuals [21–23].
The Microbleed Anatomical Rating Scale (MARS) has been intro-
duced and validated in 2009. In MARS, CMBs are classified accord-
ing to location into deep, lobar and infratentorial regions. Lobar
regions included cortical and subcortical regions, while deep loca-
tion included the basal ganglia, thalamus, internal capsule, exter-
nal capsule, corpus callosum, and deep periventricular white
matter. Brain stem and cerebellum were considered infratentorial
regions [2].
The predominant deep location of CMBs (found in about 43% of
total CMBs) implies the possibility of hypertensive arteriopathy
which is the major cause of intracerebral hematoma [2,6] Figs. 3
and 4. This also carries the risk of recurrent future attacks of stroke
[9].ciousness and right sided hemiparesis with history of hypertension. (A) T1WI shows
(B) SWI shows blooming of the haemorrhagic component of the ICH, tiny CMB is
ceptibility weighted imaging in detection of cerebral microbleeds in stroke
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Fig. 2. Female patient 33 years old, no history of hypertension, presented to the emergency hospital with sudden attack of loss of consciousness. (A) T1WI reveals
intraventricular hemorrhage. (B) SWI reveals tiny infratentorial CMB.
Fig. 3. (A–C) SWI shows left thalamic hematoma in 56 ys hypertensive female presented by stroke to emergency unit. Multiple CMBs are seen in lobar, deep and infratentorial
locations.
Fig. 4. (A–C): SWI in patient with left temporoparietal ICH; Lobar CMB in left frontal & temporal lobes (arrow in A, C), multiple deep CMB (B).
4 L.G. El-Serougy et al. / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxxThe difference in CMBs detection between the two reviewers
was due to the cases with single CMBs which were mis-
interpreted as a mimicker of CMBs. Faint or indefinite Microbleeds
were excluded to avoid further interobserver variations. The cause
of misinterpretation was similar to MARS study [2].
Limitation of the study included small number of the patients,
further studies and follow up of patients treated with anticoagu-
lants is recommended. Further studies are better adopted to test
the clinical and diagnostic significance of number of CMBs.5. Conclusion
SWI is an important reliable technique allows accurate detec-
tion of CMBs occurring in association with hemorrhage in acutePlease cite this article in press as: El-Serougy LG et al. Reliability of magnetic sus
patients. Egypt J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.20and chronic stroke and should be included in the protocols for
assessment of stroke to help in choice of proper treatment and pre-
diction of future attacks.Conflict of interest
The authors declare that there are no conflict of interests.References
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